Cargando…

Population pharmacokinetics of polymyxin B: a systematic review

BACKGROUND: Polymyxin B (PMB) is a basic cyclic polypeptide antibiotic produced by Bacillus polymyxa, and is one of the last options for treating multi-drug-resistant negative bacterial infections in clinical practice. In recent years, many population pharmacokinetic studies of PMB have been conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Na, Guo, Jianhao, Xie, Jiao, Xu, Mi, Hao, Xing, Ma, Kuifen, Rao, Yuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908148/ https://www.ncbi.nlm.nih.gov/pubmed/35280373 http://dx.doi.org/10.21037/atm-22-236

Ejemplares similares

A Review of the Clinical Pharmacokinetics of Polymyxin B
por: Avedissian, Sean N., et al.
Publicado: (2019)

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
por: Li, Ying, et al.
Publicado: (2021)

Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures
por: Tam, Vincent H., et al.
Publicado: (2020)

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
por: Wang, Peile, et al.
Publicado: (2021)

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
por: Liang, Danhong, et al.
Publicado: (2023)

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Polymyxin B and fusidic acid, a novel potent synergistic combination against Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Chen, Shuying, et al.
Publicado: (2023)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study
por: Cai, Xiao-Jun, et al.
Publicado: (2022)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
por: Zou, Dongna, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models
por: van der Meijden, Aart, et al.
Publicado: (2023)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Liu, Li, et al.
Publicado: (2020)

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
por: Cruz, Dinna N, et al.
Publicado: (2007)

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
por: Bian, Xingchen, et al.
Publicado: (2022)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Respiratory arrest associated with polymyxin B in a lung transplant patient
por: Chen, Wen-Hui, et al.
Publicado: (2020)

MTHFR polymorphism's influence on the clinical features and therapeutic effects in patients with migraine: An observational study
por: Guo, Jianhao, et al.
Publicado: (2022)

Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes
por: Loutet, Slade A, et al.
Publicado: (2011)

Polymyxin B-Induced Skin Hyperpigmentation
por: Wen, Xueke, et al.
Publicado: (2020)

Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats
por: Roy, Dilip, et al.
Publicado: (2021)

Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
por: Wang, Peile, et al.
Publicado: (2020)

Risk factors of tigecycline-associated fibrinogen reduction in patients with renal transplantation: a case-control study
por: Xie, Wenqing, et al.
Publicado: (2022)

Correlation between the drug concentration of polymyxin B and polymyxin B‐associated acute kidney injury in critically ill patients: A prospective study
por: Xu, Ying, et al.
Publicado: (2022)

Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients
por: Deng, Yang, et al.
Publicado: (2022)

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Colistin and polymyxin B: A re-emergence
por: Gupta, Sachin, et al.
Publicado: (2009)

Polymyxin B hemoperfusion: a mechanistic perspective
por: Ronco, Claudio, et al.
Publicado: (2014)

Structure-Function Studies of Polymyxin B Lipononapeptides
por: Gallardo-Godoy, Alejandra, et al.
Publicado: (2019)

Interactions of polymyxin B with lipopolysaccharide-containing membranes
por: Goode, Alice, et al.
Publicado: (2021)

Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm
por: Lakota, Elizabeth A., et al.
Publicado: (2018)

Comparison of Polymyxin E and Polymyxin B as an Additive to Pulmonary Surfactant in Escherichia coli Pneumonia of Ventilated Neonatal Rabbits
por: Stichtenoth, Guido, et al.
Publicado: (2017)

Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206
por: Bruss, Jon, et al.
Publicado: (2021)

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors
por: Cantaluppi, Vincenzo, et al.
Publicado: (2008)

Apheresis of activated leukocytes with an immobilized polymyxin B filter
por: Takeyama, N, et al.
Publicado: (2010)

Synergistic effects of Miconazole and Polymyxin B on microbial pathogens
por: Pietschmann, Silvia, et al.
Publicado: (2008)

Polymyxin B Nephrotoxicity: From Organ to Cell Damage
por: Vattimo, Maria de Fátima Fernandes, et al.
Publicado: (2016)

Polymyxin B-induced rhabdomyolysis: A case report
por: Ni, Ming, et al.
Publicado: (2020)

Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
por: Tani, Tohru, et al.
Publicado: (2019)

Adverse effects of polymyxin B administration to healthy horses
por: van Spijk, Julia N., et al.
Publicado: (2022)

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro
por: Ma, Xingyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jsdlbk5ao6spg7pnldhdoqs0cg